Albuminuria-Based CKD Screening Falls Short in At-Risk Populations
Clinicians who test for albuminuria provide better evidence-based care to their patients than those who do not, research finds.
Clinicians who test for albuminuria provide better evidence-based care to their patients than those who do not, research finds.
Study also reveals that fracture risk increases along with KDIGO risk category.
Reduction in the risk for heart failure hospitalization appears to drive a cardiovascular benefit.
Slow metabolizers of caffeine genetically comprise half of the Italian population.
Japanese guidelines recommend the use of urate-lowering drugs for the treatment of asymptomatic hyperuricemia.
7.4 year gain in event-free survival for 50-year-old patients with combo therapy with ACEi/ARB and SGLT2 inhibitors
Compared with annual screening for urinary albumin, personalized screening can reduce time spent with undetected albuminuria, testing frequency
Achieving normal blood pressure in childhood cancer survivors is “extremely important” for preventing CKD, according to investigators.
Estimated glomerular filtration rate is a less reliable predictor of CKD regression, according to investigators.
Understanding clinical characteristics associated with a decline in eGFR can help guide optimal use of SGLT2 inhibitors in clinical practice, according to investigators.